Franklin Templeton files 8-A for spot Solana ETF, indicating imminent debut
A key exchange-traded fund filing has given SOL a timely boost, setting the stage for what analysts say could be an important shift.
- Form 8-A places the Franklin Templeton Solana ETF in its final stage before listing on NYSE Arca.
- The ETF will offer spot exposure backed by actual SOL holdings and use the CF Benchmarks Solana Index.
- Launch momentum mirrors the strong inflows seen across newly listed Solana ETFs, which have topped $560M since October.
Franklin Templeton has taken a step that could shift attention back to Solana at a moment when demand for altcoin ETFs is quietly building.
The asset manager filed Form 8-A with the Securities and Exchange Commission on Nov. 25 to register the Franklin Solana ( SOL ) ETF under the Securities Exchange Act of 1934, placing the product in its final stage before trading.
The filing is the procedural trigger that typically occurs right before a new ETF begins trading, suggesting the Franklin Solana ETF could list on NYSE Arca as early as Nov. 26 or shortly thereafter.
A final step before trading begins
The 8-A filing registers the shares of the Franklin Solana Trust for exchange listing, completing the last major requirement after the S-1 amendment submitted on Nov. 21. The ETF will hold physical SOL, track the CF Benchmarks Solana Index, and follow the same structure Franklin uses across its Bitcoin, Ethereum, and newly launched XRP ETFs.
The timing is notable. Solana ETFs in the U.S., which debuted from late October, have become one of the year’s strongest altcoin ETF segments. On Nov. 25, the group logged its 20th straight day of net inflows, adding $57.99 million and pushing cumulative inflows past $560 million.
New entrants like Canary Capital and Fidelity have jumped into the market in recent weeks, giving institutions more ways to gain exposure and adding liquidity.
All of this has helped push SOL back into the $140 range. Analysts credit the rebound to consistent ETF buying and a move towards regulated altcoin exposure as major drivers.
Franklin Templeton expands crypto ETF lineup
The Solana ETF continues Franklin Templeton’s rapid expansion into digital asset products. On Nov. 25, the firm launched its spot XRP ETF (XRPZ), which posted strong first-day inflows.
Alongside the Solana Trust, Franklin has updated filings for a multi-asset crypto ETF that blends Bitcoin, Ethereum, Solana, XRP, and Cronos. It has also registered a Chainlink Trust, indicating a push into assets tied to tokenization and cross-chain settlement.
With the 8-A now filed, the Solana ETF is effectively ready for launch. If trading begins in the coming days, it will enter a market already showing a consistent appetite for SOL exposure, and may help set the tone for the next phase of altcoin ETFs heading into 2026.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Bitcoin Updates: Institutional Investors Return and Soft Policy Hints Drive Bitcoin's Significant Recovery
- Bitcoin surged above $89,000 in late November 2025, reversing a six-month low amid institutional reentry and macroeconomic optimism. - Fed rate-cut expectations (84% for December) and $238M Bitcoin ETF inflows fueled dollar weakness and crypto demand. - Coinbase's 22-day negative premium reversed, signaling easing institutional selling pressure and potential trend reversal. - Solana's $145 slump highlighted crypto divergence, while Bitcoin's $100,000 support and open interest dynamics indicated bearish e

Artificial Intelligence Applications in Biomedical Studies and Their Impact on Investment
- AI is revolutionizing drug discovery by accelerating timelines and reducing costs in pharmaceutical R&D. - Companies like Insilico Medicine and Exscientia use AI to cut drug development cycles by 70% and reduce compound testing, advancing candidates to clinical trials rapidly. - The AI-driven biotech market is projected to reach $350–410 billion annually by 2025, offering investment opportunities in AI-native firms and infrastructure providers. - However, regulatory challenges and the lack of approved AI

Internet Computer’s Latest Rally: Driven by Network Enhancements and Growing Institutional Interest
- Internet Computer (ICP) surged in 2025 due to technical upgrades, institutional partnerships, and speculative trading. - Fission/Stellarator boosted capacity by 50%, while Meridian/Flux aim to enhance cross-chain interoperability and scalability. - Q3 2025 saw $1.14B trading volume but 22.4% DApp engagement drop, highlighting infrastructure-user adoption disconnect. - TVL discrepancies ($237B vs. $1.14B) and reliance on institutional capital raise sustainability concerns amid inflated metrics. - Partners

South Korean Firm Bitplanet Boosts Bitcoin Stack to 228.5 BTC
